FDA proposes FY 2026 budget; Makary offers details on staff attrition
Regulatory NewsMichael Mezher
Biologics/ biosimilars/ vaccinesMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesRegulatory NewsMichael MezherBiologics/ biosimilars/ vaccinesMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited States